It's Time to Revisit R&D Partnerships to Fund Biotech Companies
Executive Summary
Biotechs who are agonizingly close to delivering breatkhrough products that will change medical practice cann't persuade investors to see the value that lies within this powerful industry. The solution is to reintroduce the tax breaks for investors via R&D Limited Partnerships.